The hexapeptide 275VQIINK280, encompassing the K280 residue of tau, has been proposed to be critical for tau aggregation (29), and acetylation of tau at K280 (tau-acK280) has been reported in tauopathies associated with AD and other neurodegenerative diseases (30). This evidence concerns the gene MAPT and neurodegenerative disease.